dm+d
398728003
Articles
Choosing between available adalimumab products
Safety in lactation: Drugs for chronic bowel disorders
Safety in Lactation: Systemic preparations for eczema and psoriasis
Refrigerated Storage
HumiraAbbVie
In the event of an inadvertent temperature excursion the following data may be used:
A single Humira pre-filled syringe or pre-filled pen may be stored at temperatures up to a maximum of 25°C for a period of up to 14 days. The syringe or pen must be protected from light, and discarded if not used within the 14 -day period
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
For information outside of this excursion, contact AbbVie Ltd directly. Refer to the current BNF for company contact details.
Amgevita Amgen Ltd
In the event of an inadvertent temperature excursion the following data may be used:
The pre-filled syringe or pre-filled pen may be stored at temperatures up to a maximum of 25°C for a period of up to 14 days. The pre-filled syringe or pre-filled pen must be protected from light, and discarded if not used within the 14-day period.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
ImraldiBiogen
Once exposed to temperatures up to 25°C, the syringe or pen must be used within 28 days or discarded, even if it is returned to the refrigerator.
You should record the date when the syringe or pen is first removed from refrigerator, and the date after which it should be discarded.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
HyrimozSandoz
In the event of an inadvertent temperature excursion the following data may be used:
A single Hyrimoz pre-filled syringe / pre-filled pen may be stored at temperatures up to a maximum of 25°C for a period of up to 21 days. The pre-filled syringe / pre-filled pen must be protected from light, and discarded if not used within the 21-day period.
The manufacturers have stated that they will deal with temperature excursions on a case by case basis to ensure the most up to date information is provided each time.
Refer to the electronic medicines compendium (eMC) at www.medicines.org.uk/emc/ for company contact details.